Europe
The results of Lumasiran were presented at the European Renal Association-European Dialysis and Transplant Association International Congress.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 8, 2020.
Shares of Gilead Sciences jumped in pre-market trading this weekend following reports that the company has been approached by U.K. pharma giant AstraZeneca regarding a potential merger.
The next two weeks are busy ones for the U.S. Food and Drug Administration (FDA). Here’s a look at PDUFA dates for this period.
As summer begins, we’re seeing a shift away from COVID-19-related news and a stronger output of other clinical trial news. Here’s a look.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 5, 2020.
UK-based AstraZeneca and the University of Oxford have partnered on the global development and distribution of Oxford’s COVID-19 vaccine, AZD1222.
Biopharma and life sciences companies bolster their leadership teams and board with these Movers & Shakers.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
The fund, called the Emergency Support Instrument, would be used to increase vaccine manufacturing capacity in Europe.
PRESS RELEASES